Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Veterinary Vaccines Market Report by Vaccine Type, Technology, Route of Administration, Distribution Channel, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.
The veterinary vaccines market has attained an impressive valuation of US$ 13.6 Billion in 2023 and is forecasted to nearly double, reaching a valuation of US$ 28.0 Billion by the year 2032. Experts predict a sustained growth rate (CAGR) of 8.35% during the forecast period of 2023-2032, driven by various factors including rising demand for livestock and pets worldwide. The acknowledgment of vaccines in preventing zoonotic diseases and their role in enhancing the health and productivity of domestic animals has augmented the expansion of veterinary immunizations. 
Technological advancements play a pivotal role in the veterinary vaccines industry, with novel vaccines being developed to offer heightened stability and efficacy. Breakthrough developments such as RNA and DNA vaccines, and the innovative intramuscular needle-free injection method are accelerating market growth. These advancements have significantly contributed to improved animal welfare, increased awareness regarding vaccine benefits, and the amplified need for preventing disease in both companion and livestock animals.
Market Segmentation Insights
The market is segmented into various categories, including vaccine type, technology, and route of administration. Breakdown by vaccine type demonstrates a comprehensive range that covers livestock to companion animals, indicating a balanced demand across different animal categories. Technology segmentation shows a diverse mix of conventional and advanced vaccine production methodologies, underlining the industry's adaptive approach to vaccination technology. Administration route insights reveal user preference trends and the practical focus on achieving maximal immunization effectiveness and compliance.
Regional Perspectives
A geographical examination of the market illustrates substantial activity levels across North America, Asia-Pacific, Europe, Latin America, as well as the Middle East and Africa. This global perspective points to the universal importance placed on veterinary vaccines for the health of animals and public safety. As such, regional analysis offers critical insights for stakeholders to understand localized market dynamics and optimize their strategic approaches accordingly.
Industry Competitive Landscape
The market's competitive landscape highlights a robust and diverse array of players. Incumbents are focused on continuous innovation and strategic alliances to advance vaccine efficacy and distribution. The industry structure is supportive of both established entities and newer entrants, reflecting a dynamic and competitive environment where quality and innovation are rewarded.
Forward-Looking Evaluation
Overall, these insights substantiate the growing impetus in the veterinary vaccines market and its critical role in the wider animal health and pharmaceutical sectors. With animal welfare and public health at the fore, the industry is poised for robust growth and continued advancements over the next decade.
The information herein reflects a thoughtful compilation of market dynamics, technological innovations, and future trends being realized in the veterinary vaccines market globally. With sustained research and strategic collaborations, the industry is expected to thrive, driven by an unwavering commitment to enhancing animal welfare and human safety through preventative healthcare measures.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 149 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value (USD) in 2023 | $13.6 Billion |
| Forecasted Market Value (USD) by 2032 | $28 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
Companies Featured
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
- Elanco Animal Health Incorporated
- Hester Biosciences Limited
- HIPRA
- Indian Immunologicals Limited
- Merck & Co. Inc.
- Neogen Corporation
- Phibro Animal Health Corporation
- Virbac SA
- Zoetis Inc.
For more information about this report visit https://www.researchandmarkets.com/r/vpmohw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
